January 13, 2022
C-Path Launches Rare Disease Clinical Outcome Assessment Consortium
Related Posts
-
The CPP Consortium Welcomes Biohaven as its Newest Member -
C-Path and EATRIS Join Forces with New Collaboration Agreement -
C-Path’s Rare Disease Clinical Outcome Assessment Consortium Launches Rare Disease COA Resource -
NIDDK Central Repository 20th Anniversary Workshop: Promoting Secondary Research to Accelerate Medical Breakthroughs and Innovation -
Fall 2023 HRA Members Meeting